Other Speciality Chemical Stocks and Companies in India

The largest Other Speciality Chemical stocks in India by market value are Sudeep Pharma (₹12,613 crore), Jubilant Agri & Consumer Products (₹2,901 crore) and Chembond Chemicals (₹570 crore), at prices of 4 Nov 2026.

• Sudeep Pharma: ₹1,116.70 | market value ₹12,613 crore | P/E 67.0
• Jubilant Agri & Consumer Products: ₹1,914.70 | market value ₹2,901 crore | P/E 21.8
• Chembond Chemicals: ₹212.03 | market value ₹570 crore | P/E 16.6

Share price | market value | P/E, biggest first. Prices, market values and ratios at the official close of 4 Nov 2026; the score list below uses the weekly figures.

All 3 listed Indian Chemicals - Speciality companies are named here, largest first. This is the set of companies people mean when they search for a Nifty Chemicals - Speciality index; NSE publishes its own indices only for the largest sectors, so this equal-weighted set stands in for one. One large company cannot set the reading.

1. Sudeep Pharma Ltd₹12,100 cr
2. Jubilant Agri & Consumer Products Ltd₹2,900 cr
3. Chembond Chemicals Ltd₹549 cr

3 Other Speciality Chemical companies in the Chemicals - Speciality industry group have a page on Sector Alpha, by market value as of 30 October 2026, and all 3 are listed below, largest first. The largest is Sudeep Pharma (₹12,066 crore) and the smallest with a market value is Chembond Chemicals.

Download all 3 Other Speciality Chemical companies (CSV)

The line below covers up to 1.7 years. There is not enough history yet to compare this sector with NIFTY 500 over two years. Earnings across its companies grew 26% on average over the last four reported quarters. It has been ahead of NIFTY 500 on a rolling three-month view for 29 weeks running.

0 of 3 companies pass the momentum test (5+ points ahead of the Nifty 500 over 3 months, within 20% of the 52-week high).

Ahead of NIFTY 500 on the three-month view for 29 weeks running; 2 of the 3 companies in the industry index above their 200-day average (1 fewer than four weeks earlier); 0 of those 3 pass the momentum test (1 fewer than four weeks earlier); earnings direction not measurable.

Participation is shrinking, 1 → 0 of 3 over four weeks, after being ahead of NIFTY 500. Earnings not called, only 2 of 3 members have four comparable quarters on file, and three is the floor for a reading.

Both lines start at 200 in the same week, so the gap between them tells the story: the sector line is an equal-weighted index of its 3 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member set to 100 at the start and the sector taking the middle value, so a price line pulling away from flat bars means the market is paying more for the same earnings. A bar turns grey when that figure is lower than the quarter before. The rules are fixed and the same everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover or tap any point to read both values and the gap.

Chemicals - Speciality has done better than the NIFTY 500 by 1.5% over the last 52 weeks. Over 13 weeks the gap is a lead of 17%.

Chemicals - Speciality has done better than the NIFTY 500 by 1.5% over 52 weeks and by 17% over 13 weeks. 0 of 3 companies we track are beating the NIFTY on relative strength (how a share price has done against the index over recent months) (1 has no relative-strength reading yet).

A score that ranks each company against the others in its industry. The four parts shown always add up to the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or old evidence affects only its own part, never as a hidden adjustment.

Sudeep Pharma Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 70% evidence confidence.

Sudeep Pharma Ltd has the strongest one-year price move in Chemicals - Speciality at +38.0%. Chembond Chemicals Ltd leads on relative strength against the NIFTY, at +13.9%. 2 of 3 companies we track are ahead of the index on that measure (1 has no relative-strength reading yet). Every line covers 313 weekly closes through 30 October 2026.

Price and relative strength

Price · same starting point: Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts: the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.

RS vs NIFTY 500: How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.

RS vs sector: The same measure taken against Chemicals - Speciality itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.

Biggest one-year moves

Strongest against NIFTY 500

Only five companies sit in it, and the whole 12-year annual history is really the last six years, because before 2020 just one or two of them reported at all. On the numbers the growth is genuine and of the durable kind: sector profit went from ₹278 crore to ₹337 crore in a year, and the dominant leg was sales (+25.1%) rather than margin, which was actually a small drag of about a third of a percentage point. In the week of 17 August 2026, 100% of 5 Chemicals - Speciality companies were beating the Nifty 500.

From our industry review of 22 August 2026. A newer review (10 October 2026) did not cover Chemicals - Speciality, so this is the latest we have.

2 of 6 Chemicals - Speciality companies held a results call for April to June 2026. Gem Aromatics guided: Safranal revenue contribution towards the end of July to September 2026, with a more meaningful contribution from October to December 2026 as supplies scale.

From the results calls for April to June 2026.

Big funds, foreign and Indian, cut their stake by 0.5 points over the last two quarters. Founders and promoters kept theirs about the same.

• Spending on new plants and equipment was ₹377 crore in the last 12 months, 192% more than a year before.
• Projects still being built grew 89% in a year.

Big funds = foreign and Indian institutions, change in their share of ownership across 4 Chemicals - Speciality companies, in percentage points.

Ownership and spending as of 10 October 2026.

If Sudeep Pharma's speciality growth does NOT return to the 20%-plus track in the September quarter once the cooking-gas supply normalises, the margin loss was demand, not plumbing, and the whole sales inflection this verdict rests on becomes suspect. The mirror image would also break it: if the next annual print shows sector operating margin falling again from 16.05% while the capital-spending flood (up 226.98%, construction-in-progress up 98.17%) starts landing as depreciation, then this is capacity arriving into a softening margin, not a turn. Either print is visible in one quarter.

From our industry review of 10 October 2026.

Jubilant Agri & Consumer Products Ltd has the highest Revenue among the 3 Chemicals - Speciality companies compared here, at ₹1,943 crore. Sudeep Pharma Ltd is next at ₹709 crore. Chembond Chemicals Ltd has the highest Revenue growth at 27%, so level and change sit with different companies. Its Revenue series carries 11 reported observations across the 16-quarter window.

What the numbers say: Jubilant Agri & Consumer Products Ltd is the largest at ₹1,943 crore, 174% ahead of Sudeep Pharma Ltd. Chembond Chemicals Ltd's growth is 27% from a ₹370 crore base, with 10 reported quarters out of the last 20. Fast growth from a smaller base is not yet the same as proven size.

What this means: Jubilant Agri & Consumer Products Ltd is the size to compare against; Chembond Chemicals Ltd is the one growing fastest. The faster grower has to keep that growth and turn it into margin and returns before it counts as more than a fast start.

This conclusion weakens if: Jubilant Agri & Consumer Products Ltd's growth falls below Chembond Chemicals Ltd's for two consecutive comparable reports while operating margin also compresses.

Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.

Revenue · company comparison

Revenue · largest

Revenue growth · fastest growers

All-company data · latest reported quarter

In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

Revenue shows both size and speed. A large company can absorb shocks and pay for wide distribution; faster growth can mean market-share gains, new capacity or stronger demand. The best sign is usually growth that lasts without hurting margins and returns.

Sudeep Pharma Ltd has the highest OPM among the 3 Chemicals - Speciality companies compared here, at 37%. Jubilant Agri & Consumer Products Ltd is next at 13%. The same company also has the highest Margin change, at +3 percentage points. 3 of 3 companies report a comparable reading, the latest through Sep 2026.

What the numbers say: Sudeep Pharma Ltd leads both opm at 37% and margin change at +3 percentage points.

What this means: Sudeep Pharma Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.

Operating margin · company comparison

OPM · highest

Margin change · fastest expanders

All-company data · latest reported quarter

Sudeep Pharma Ltd has the highest Net profit among the 3 Chemicals - Speciality companies compared here, at ₹190 crore. Jubilant Agri & Consumer Products Ltd is next at ₹131 crore. Jubilant Agri & Consumer Products Ltd has the highest Profit growth at 26%, so level and change sit with different companies.

What the numbers say: Sudeep Pharma Ltd earns the most, ₹190 crore of profit over the last 12 months, 45% above Jubilant Agri & Consumer Products Ltd. A fast rate from a small base matters less than a large profit that keeps coming.

What this means: Sudeep Pharma Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.

Net profit · company comparison

Net profit · largest

Profit growth · fastest growers

All-company data · latest reported quarter

Jubilant Agri & Consumer Products Ltd has the highest ROCE among the 3 Chemicals - Speciality companies compared here, at 40.4%. Sudeep Pharma Ltd is next at 28.2%. Sudeep Pharma Ltd has the highest ROCE change at −1.4 percentage points, so level and change sit with different companies. Its ROCE series carries 9 reported observations across the 16-quarter window.

What the numbers say: Jubilant Agri & Consumer Products Ltd leads ROCE at 40.4%, 12.2 percentage points above Sudeep Pharma Ltd. A high return reported once may be one good year; a high return reported year after year shows a lasting business.

What this means: Jubilant Agri & Consumer Products Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.

Return on capital · company comparison

Withheld from this chart: Chembond Chemicals Ltd (CHEMBONDCH): its two data sources disagree by up to 184% on reported income across 10 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn, the gap is a decision, not missing data.

ROCE · highest

ROCE change · fastest improvers

All-company data · latest reported quarter

Jubilant Agri & Consumer Products Ltd has the lowest PEG among the 3 Chemicals - Speciality companies compared here, at 0.51×. Sudeep Pharma Ltd is next at 4×. Chembond Chemicals Ltd has the lowest P/E at 16×, so level and change sit with different companies. 2 of 3 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Jubilant Agri & Consumer Products Ltd has the lowest comparable PEG at 0.51×, 87.3% below Sudeep Pharma Ltd. That would need today's multiple, the company's own history and steady growth to agree.

What this means: A low valuation is a reason to look closer at the business, not a conclusion on its own.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is worked out the same way every time, as the P/E on the last 12 months of reported earnings divided by that growth rate, never on expected earnings. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.

Valuation · company comparison

PEG · lowest PEG

P/E · lowest P/E

All-company data · latest reported quarter

None of the 3 Chemicals - Speciality companies is on one of our India lists this week.

This Chemicals - Speciality comparison names 6 specific ways its own evidence can mislead, all listed below. All 3 companies here report on comparable dates, so no rank carries a stale marker. 1 has second-source figures left out because the two sources disagree. 1 of the 5 ranked sections has fewer than three usable current readings.

Keep these limits visible

• A high growth rate can come from a very small starting figure. The page keeps level and change separate for that reason.
• A high ROCE can be temporary, or look high because the capital base is small. It is best read beside margin, cash flow and how much is spent back on the business.
• The 4-Factor Sector Score ranks published data only. Management quality, upcoming events and risks are not part of it.
• An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
• 1 company is missing from the second-source figures on purpose: the two sources disagree, so nothing from the second is drawn. Those rows have less evidence; that does not make the business weaker.
• Thin comparisons: Valuation have fewer than three usable current readings.

This comparison is built from the reported filings of 3 Chemicals - Speciality companies, normalized to a common ₹ scale and a shared quarter axis of up to 16 quarters each. Fundamentals run through Sep 2026 and market data through 30 October 2026.

1 of 3 companies has a second data feed that is known to disagree with the primary source, so nothing from it is drawn: Chembond Chemicals Ltd (CHEMBONDCH): its two data sources disagree by up to 184% on reported income across 10 comparable periods, so its derived ratios are withheld.

These 23 answers restate the Chemicals - Speciality comparison above in question form. Every one is computed from the same 3 companies and the same reported filings as the rankings and charts, current through Sep 2026. Price and relative-strength answers run through 30 October 2026. Nothing here is estimated, and none of it is a recommendation.